History
Growth
- Listed on the KOSDAQ market in 2015.
- Acquisition of Sungwoon Bio in 2017 (currently GF Permanentech)
- Technology
- - Efficient special enzyme development process (3 years -> 1 year)
- - 150 tons industrial fermentation production
- Sales
- Securing excellent customers and launching special enzymes.
- Leaping into a biotherapeutics developing company.
- 2020
-
- 08 Development of human disease models such as IBD and Wet AMD in mini pigs.
- 08 Development of Proteinase-K, an essential enzyme for COVID-19 diagnosis.
- 02 10 billion won worth of investment attraction.
- 2018
-
- 10 Establishment of BiomLogic, a subsidiary specializing in new drug development.
- 2017
-
- 06 Discovered GF103 as a candidate for pharmaceutical products.
- 03 Acquisition of Sungwoon Bio (Currently GF Fermentech)
- 2016
-
- 11 Lactase US FDA GRAS acknowledged.
- 10 30.8 billion won worth of investment attraction.
- 2015
-
- 05 KOSDAQ Market Listed
- 2013
-
- 08 Hydrogen peroxide decomposing enzyme in semiconductor factory cleaning solution. Sales of Katalase S 350L started.
- 2012
-
- 05 Establishment of 100% subsidiary in China. (GenoFocus Biotechnology Ltd.)
Take-off
- Development of Catalase mass production process in 2010
- technology
- Customized enzyme development and production technology.
- - Enzyme improvement technology
- - recombinant protein secretion technology
- sales
- Service & customized enzyme.
- 2011
-
- 11 Katalase S sales started. Hydrogen peroxide decomposing enzyme for the use in fibers.
- 10 Technology transfer of GOS production to company Q (USD 600,000)
- 2010
-
- 11 Completed development of TL Lipase production technology for manufacturing raw medicinal material.
- 11 Catalase mass production process development completed.
- 2008
-
- 12 Selected for civil and military technology development project (Defense Acquisition Program Administration): developing eco-friendly decontamination agents for chemical/biological weapons.
Establishment
- 2001 Certified as a venture company.
- 2002 Selected as INNO-BIZ company.
- Technology
- Customized protein development platform tech.
- - Molecular evolution technology
- - Microbial surface display technology
- sales
- Technology service.
- 2004
-
- 10 2 nd CEOinauguration:EuiJoongKim
- 2002
-
- 12Selected as INNO-BIZ company
- 2001
-
- 05 Selected as national designated laboratory by Ministry of Science and ICT: Microbial surface display platform technology.
- 02 Certified as venture company
- 2000
-
- 03Korea Research Institute of Bioscience and Biotechnology spin-off founded.
(Founder: Jae-Gu Pan, current CTO)
- 03Korea Research Institute of Bioscience and Biotechnology spin-off founded.